Boardman, A. P., Reguera, J. L., Wang, P., Ellis, J., Bar, M., Kumar, J., Farazi, T. A., Garcia-Sancho, A. M., Izutsu, K. (2025). Matching-adjusted indirect comparison (MAIC) of lisocabtagene maraleucel (liso-cel) versus axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) for treatment of third-line or later (3L+) R/R follicular lymphoma (FL): Update with 24 months of liso-cel follow-up (FU).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e19049